drugset / Trial / NCT00542880

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®

NCT00542880 ↗

Phase 4 Completed 442 enrolled AstraZeneca
RandomizedCrossoverTriple-blindTreatment

Summary

This study is to assess the effects with two different inhaled respiratory medications with regards to improvement of lung function, symptoms and morning activities.

Timeline

Start
2007-09
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject budesonide/formoterol Unknown 9 ug Inhaled
Subject budesonide/formoterol Unknown 320 ug Inhaled
Subject salmeterol/fluticasone Unknown 50 ug Inhaled
Subject salmeterol/fluticasone Unknown 500 ug Inhaled